HealthVerity discusses several challenges when it comes to using deidentified patient data. Although using patient information can provide unique insight, it can be time-consuming to wade through the different types and sources of RWD (real world data). At the same time, data security must remain a priority. In addition to these challenges, HealthVerity also proposes several solutions.
“A data-rich longitudinal patient journey is key to research and development, commercialization and marketing in the world of life sciences and pharmaceuticals. But how does a comprehensive patient journey come to fruition? At its core is high-quality de-identified patient data, matched across myriad data sources in a HIPAA-compliant, privacy-protecting manner.” Read more here.
(Source: HealthVerity, 2021)